What Does MACD Oscillator Analysis predict about Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)?

126

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) for the period of 9-Day stands at 62.39% while the stochastic %D for the same period stands at 50.8%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Corbus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics to treat life threatening (orphan) inflammatory-fibrotic diseases. The Company’s lead product is Resunab (TM), an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and scleroderma. Corbus Pharmaceuticals Holdings, Inc. is based in Norwood, Massachusetts.

Previous Day Activity Analysis

On the last trading day, Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) opened the session at $7.3 and after going down -5.52% closed at $6.85. The stock lost -0.45 points in the last trade.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)’s stock fluctuated in the range of $6.85 and $7.30 during the previous active session. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) traded with the volume of 881754 with average volume of 678.86 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.4 and 46.64 respectively.

Currently the Insider Ownership of the shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is at 2% and the shares outstanding are 53.37 Million.

Important Ratio Analysis

Some important ratios to consider here for Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 130.57 and 10.7 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 9.99 and 0 correspondingly.

The Quick Ratio of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stands at 6 while the Current Ratio depicts the value of 6.

Return on Assets ROA of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is at -77.4% whereas, Return on Equity ROE and Return of Investment ROI of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) stand at -96% and -217.2% respectively.

Stock Performance Analysis

The stock performance of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) on the basis of 5 day trade show the dip of -1.44% whereas, the monthly performance of the stock shows increase of 0.74%.

The quarterly performance of the stock remained in green zone with the value of 14.64% while six month performance of the shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) remained bullish with the count of 4.58%.

The yearly and YTD performance of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) remained mix at 17.09% and -18.93% respectively.

LEAVE A REPLY